Guru Ownership Trend
Guru Analysis for Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $75.21 M.
Top institutional holders include Steven Cohen and Catherine Wood.
Institutional sentiment is currently Bullish. This is evidenced by a $6.43 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 11.9%. Conversely, Paul Tudor Jones reduced exposure by 8.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Nurix Therapeutics, Inc. (NRIX)
Major holders include Steven Cohen ($60.93 M), Catherine Wood ($30.4 M), Paul Tudor Jones ($659,397). According to the latest reported data, 3 tracked investment managers collectively hold approximately 4.85 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.43 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited NRIX. The total reported sell value was $1.77 M.
Yes, 0 managers opened new positions in NRIX, and 2 increased their existing holdings. The total reported buy value was $8.2 M.